Johnson & Johnson ordered to pay $4.69 billion in talc case

Photo credit: Jeff Chiu/Associated Press as reported by The New York Times on 7/12/18.

Photo credit: Jeff Chiu/Associated Press as reported by The New York Times on 7/12/18.

Johnson & Johnson, in one of the largest punitive damage awards in history, must pay $4.69 billion to plaintiffs exposed to talcum-based products which they claimed caused them to develop cancer.

“Johnson & Johnson was ordered Thursday to pay $4.69 billion to 22 women and their families who had claimed that asbestos in the company’s talcum powder products caused them to develop ovarian cancer,” The New York Times reported on July 12. “A jury in a Missouri circuit court awarded $4.14 billion in punitive damages and $550 million in compensatory damages to the women, who had accused the company of failing to warn them about cancer risks associated with its baby and body powders.”

Six of the women who sued the company have died, according to The New York Times. Johnson & Johnson, which has successfully appealed a number of similar cases, vowed to file an appeal.

L.A. Jury Awards Record $417 Million In Talc Cancer Case

 

The plaintiff, Eva Echeverria, was diagnosed with ovarian cancer in 2007. PhotoCredit: The Los Angeles Times online article, 8/21/2017

The plaintiff, Eva Echeverria, was diagnosed with ovarian cancer in 2007. PhotoCredit: The Los Angeles Times online article, 8/21/2017

The Los Angeles Times is among those reporting on a $417-million verdict against Johnson & Johnson over the company’s talc product, In effect, the jury found the company liable because it did not warn a 63-year-old woman diagnosed with terminal ovarian cancer about the talcum cancer risks.
The Times noted that “… verdict marks the largest award yet in a number of suits claiming that the company’s talc powder causes ovarian cancer. More than 300 lawsuits are pending in California and more than 4,500 claims in the rest of the country, alleging that the healthcare giant ignored studies linking its Johnson’s Baby Powder and Shower to Shower products to cancer.”
The company says it will appeal, insisting that science is on its side. But the Times explained that the L.A. lawsuit “… cited a 1982 study that shows women who used talc on their genitals were at a 92% increased risk for ovarian cancer. The lead researcher, Daniel W. Cramer, later advised Johnson & Johnson to put a warning label on the product.”
The newspaper also backgrounded that “… ovarian cancer accounts for 1.3% of all new cancer cases in the U.S., according to the National Cancer Institute. But it is the eighth most common cancer and the fifth-leading cause of cancer-related death among women. Fewer than half of all patients survive five years after a diagnosis.”

Read the LAT report here: L.A. jury hits Johnson & Johnson with $417-million verdict over cancer link to its talc